RS
ELV icon

Robeco Schweiz’s Elevance Health ELV Stock Holding History

Robeco Schweiz’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,677
Closed -$8.94M – 136
2022
Q3 		$8.94M Hold
19,677
– – 0.17% 103
2022
Q2 		$9.5M Buy
19,677
+212
+1% +$105K 0.17% 102
2022
Q1 		$9.56M Buy
19,465
+1,988
+11% +$909K 0.13% 112
2021
Q4 		$8.1M Buy
+17,477
New +$7.35M 0.11% 113

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Robeco Schweiz's ELV Position: Q4 2022 in Review

Robeco Schweiz sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 19,677 shares — an estimated $8.94M sold.

Robeco Schweiz first reported a position in ELV in Q4 2021 and held it in 4 quarters. The position peaked at $9.56M in Q1 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Robeco Schweiz reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Robeco Schweiz sold 19,677 Elevance Health shares in Q4 2022, an estimated $8.94M.
  • Robeco Schweiz first reported a position in Elevance Health in Q4 2021 and held it in 4 quarters.
  • Robeco Schweiz's Elevance Health position peaked at $9.56M in Q1 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Robeco Schweiz's 13F filing for Q4 2022, filed 7 Feb 2023.